The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pharma Mar’s lurbinectedin (Zepzelca) to treat ...

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored ...

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of ...

Eli Lilly and InnoCare Pharma, a biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, have ...

Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate ...

CSL Seqirus has announced a strengthened partnership with the UK government that will see the UK become the first country in ...

That plurality matters because the strongest answer rarely comes from one point of view, but from several being tested ...

Join Impetus Digital's pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static ...

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases ...